WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

Strona główna・Stock List・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Closed

SectorConsumer defensive

6.52 -0.76

Buy Sell

Overview

Share price change

24h

Current

Min

6.42

Max

6.54

Key metrics
By Trading Economics
Income	-7.9M -10M
Sales	-5.3M 31M
Profit margin	-32.116
Employees	406

Dividends
By Dow Jones
Next Earnings	16 mar 2026

Market Stats
By TradingEconomics
Market Cap	-12M 229M
Previous open	7.28
Previous close	6.52

News Sentiment

By Acuity

50%

48 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 mar 2026, 21:14 UTC

Major News Events

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mar 2026, 21:14 UTC

Major News Events

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mar 2026, 00:00 UTC

Major News Events

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mar 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mar 2026, 23:44 UTC

Market Talk

Major News Events

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mar 2026, 23:35 UTC

Market Talk

Major News Events

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mar 2026, 23:00 UTC

Acquisitions, Mergers, Takeovers

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mar 2026, 22:37 UTC

Market Talk

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mar 2026, 22:18 UTC

Market Talk

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mar 2026, 22:14 UTC

Earnings

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mar 2026, 22:14 UTC

Earnings

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mar 2026, 22:14 UTC

Earnings

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mar 2026, 22:14 UTC

Earnings

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mar 2026, 22:14 UTC

Earnings

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mar 2026, 22:00 UTC

Major News Events

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar 2026, 22:00 UTC

Major News Events

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar 2026, 03:00 UTC

Major News Events

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mar 2026, 15:00 UTC

Major News Events

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mar 2026, 02:03 UTC

Earnings

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mar 2026, 01:32 UTC

Acquisitions, Mergers, Takeovers

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mar 2026, 00:29 UTC

Acquisitions, Mergers, Takeovers

13D Filings -- Barrons.com

13 mar 2026, 22:27 UTC

Market Talk

Major News Events

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar 2026, 22:13 UTC

Market Talk

Major News Events

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar 2026, 22:04 UTC

Market Talk

Major News Events

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar 2026, 22:00 UTC

Acquisitions, Mergers, Takeovers

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar 2026, 20:50 UTC

Market Talk

Major News Events

Financial Services Roundup: Market Talk

13 mar 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar 2026, 19:50 UTC

Market Talk

Major News Events

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar 2026, 19:35 UTC

Major News Events

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Peer Comparison

Price change

Lifecore Biomedical Inc Forecast

Rating Consensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Lifecore Biomedical Inc - Dist in the past 3 months.

Sentiment

By Acuity

48 / 131 Ranking in Consumer defensive

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.